The story of how Asphalion, a leading scientific and regulatory consultancy operating across 16 countries, managing 124 products and 28 projects throughout Europe, streamlined pharmacovigilance literature monitoring with DrugCard.
Challenges of Overseeing a PV Portfolio Across Multiple Jurisdictions
Overseeing a pharmacovigilance portfolio across multiple jurisdictions came with several significant challenges for Asphalion:
- First, reviewing literature for a large number of products across 16 countries was time-intensive.
- Furthermore, the low yield of safety-relevant articles rendered the process inefficient.
- Adding to the complexity, managing article screening and translations for multilingual sources required careful coordination.
- Maintaining consistent quality and oversight across 28 concurrent projects demanded constant vigilance and organisation.
As a result, managing a PV portfolio across multiple countries created complex operational challenges for Asphalion.
The Solution: Enhancing Pharmacovigilance Efficiency with DrugCard
To tackle these challenges, Asphalion seamlessly integrated DrugCard into its workflow, unlocking several powerful capabilities:
- Automated literature screening across local and global sources, including PubMed
- AI-assisted classification to quickly pinpoint safety-relevant articles
- Streamlined translation workflows for multilingual content
- QC reports and compliance checks to ensure consistent oversight
- ICSR detection using the adverse reaction database
This integration allowed Asphalion to work faster, smarter, and more efficiently across multiple jurisdictions.
The Results: 94% Faster Article Reviews with DrugCard
With DrugCard, Asphalion transformed its pharmacovigilance workflow:
- Reviewing articles in just ~1.5 minutes each
- Automated translations to ensure accurate evaluations
- Boosting productivity with a 94% reduction in time per article
- Enhancing oversight through new QC reporting tools
- Gaining clear visibility into project-specific performance
As a result, this streamlined approach enabled Asphalion to work more efficiently, maintain high quality, and stay entirely on top of its PV portfolio.
Ready to Achieve Similar Results?
Instead of letting manual article screening hold your team back, DrugCard enables you to automate literature monitoring, accelerate safety case detection, and maintain compliance across all regions.
See the impact for yourself – book your demo today.
